FMS
$21.64-0.47 (-2.13%)
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally.
Intraday
Recent News
Fresenius Medical Care AG (FMS) Looks to Improve Profitability After Smashing Q4 Expectations
Fresenius Medical Care AG (NYSE:FMS) is among the best German stocks to buy according to analysts. On February 24, Fresenius Medical Care AG (NYSE:FMS) released its Q4 2025 results. The company posted EPS of €1.14, compared to €0.23 in the same quarter in 2024. It delivered revenue of €5.1 billion, flat from the year-ago quarter. […]
Here's Why Fresenius (FMS) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Assessing Fresenius Medical Care (XTRA:FME) Valuation After Recent Share Price Softness
What Fresenius Medical Care’s Recent Moves Mean for Investors Fresenius Medical Care (XTRA:FME) has drawn fresh attention after recent share price moves, with the stock down slightly over the past week but showing a small gain over the past month. See our latest analysis for Fresenius Medical Care. The recent 2.8% 30 day share price return contrasts with a weaker year to date share price return of 4.8% and a 1 year total shareholder return of 12.6%, suggesting momentum has been fading...
FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand
FMS tops Q4 estimates as EPS jumps 59% and margins expand, powered by savings from its FME25+ program despite portfolio-optimization-driven sales pressure.
Fresenius Medical Care AG & Co. KGaA Q4 2025 Earnings Call Summary
Moby summary of Fresenius Medical Care AG & Co. KGaA's Q4 2025 earnings call